ABSTRACT
While optical properties of graphene in the visible region are solely defined by the frequency-independent fine structure constant, an onset of absorption has been observed in the infrared region due to Pauli blocking of interband transitions. Here, we report a complete absorption quenching in the infrared region by coating graphene with bis(trifluoromethanesulfonyl)amine (TFSA), an optically transparent p-type chemical dopant. The Fermi level downshift due to TFSA doping results in enhanced transmission in the infrared region proportional to the doping concentration. An absorption quenching onset method, developed in our work, to extract the Fermi level shift in pristine and doped graphene agrees with values extracted from Raman G-band and 2D-band shifts, Hall measurements and the binding energy shift observed in X-ray photo-electron spectroscopy. Performing simple UV-visible transmittance spectroscopy to obtain the absorption quenching onset of graphene also allows detection of environmental and substrate effects via Fermi level shift. Our method opens up the practical implementation of this unique phenomenon of graphene in future optoelectronic devices.
ABSTRACT
We report that vertically aligned ZnO nanowire arrays (ZnO NWAs) were fabricated on 3D graphene foam (GF) and used to selectively detect uric acid (UA), dopamine (DA), and ascorbic acid (AA) by a differential pulse voltammetry method. The optimized ZnO NWA/GF electrode provided a high surface area and high selectivity with a detection limit of 1 nM for UA and DA. The high selectivity in the oxidation potential was explained by the gap difference between the lowest unoccupied and highest occupied molecular orbitals of a biomolecule for a set of given electrodes. This method was further used to detect UA levels in the serum of patients with Parkinson's disease (PD). The UA level was 25% lower in PD patients than in healthy individuals. This finding strongly implies that UA can be used as a biomarker for PD.